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ABSTRACT
TRANSPATH  is a database about signal transduc-
tion events. It provides information about signaling
molecules, their reactions and the pathways these
reactions constitute. The representation of signaling
molecules is organized in a number of orthogonal
hierarchies reflecting the classification of the mole-
cules, their species-specific or generic features, and
their post-translational modifications. Reactions are
similarly hierarchically organized in a three-layer
architecture, differentiating between reactions that
are evidenced by individual publications, general-
izations of these reactions to construct species-
independent ‘reference pathways’ and the ‘semantic
projections’ of these pathways. A number of search
andbrowseoptionsalloweasyaccesstothedatabase
contents, which can be visualized with the tool
PathwayBuilder . The module PathoSign adds data
about pathologically relevant mutations in signaling
components, including their genotypes and pheno-
types. TRANSPATH  and PathoSign can be used as
encyclopaedia,inthe educational process, forvizual-
ization and modeling of signal transduction net-
works and for the analysis of gene expression data.
TRANSPATH  Public 6.0 is freely accessible for
users from non-profit organizations under http://
www.gene-regulation.com/pub/databases.html.
INTRODUCTION
Living cells have to interact intimately with their environment
through exchanging a huge variety of signals. In particular the
cells of higher eukaryotes have not only to react to extra-
organismic stimuli but also to all the signals transmitted
from other cells and organs of the same organism in order to
coordinate their activities. In many, if not most, cases respond-
ing to such a signal implies to adapt the presently active gen-
etic program of the receiver cell. To achieve this, the signal
has to be forwarded to the nucleus which occurs via more or
less complex signaling pathways. Many of these pathways
have the property of a cascade, enabling the input signal to
be multiplied on several steps.
Many of these signaling pathways, which may combine to
networks and circuits through all kinds of cross-talks, have
been unraveled until now and actually have been a matter of
intense biochemical and molecular biological research since
decades. The need to store this huge body of information
in a computer-readable format was recognized early, when
CSNDB started its pioneering work in this ﬁeld (1,2), followed
by TRANSPATH  (3), and a couple of further databases and
information resources on the same subject such as PATIKA
(4), aMAZE (5) or STKE (www.stke.org). During the last
years, the TRANSPATH  database was subject to consider-
able expansion of its contents as well as changes of its data
structure (6–8), the latest of them to be reported here. Among
the most important changes, the method how variants and
homologous molecules are represented, and the way to
describe post-translational modiﬁcations (PTMs) and their
effects will be reported.
DATA STRUCTURE
Basically, allsignalingpathwaysinTRANSPATH  havebeen
modeled as bipartite graphs with molecules and reactions as
node classes. Each molecule is linked to the reaction entries in
which it participates, and each reaction entry is linked to the
entries of molecules involved. Both components, molecules
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ponents even in multiple hierarchies.
Molecule hierachies
The published data on signaling pathways and the molecular
components involved differ largely in their granularity. Occa-
sionally, certain features may have been assigned to whole
families only, and this may have been done not because it is
known that all members of that family share this property, but
rather it is unkown exactly which family member exhibited
this behavior in an investigated context. In this sense, all
proteins or, more precisely, polypeptides, encoded by one
gene form one such group as well, and only in a subset of
reported experiments we can assign the reported property to an
individual polypeptide. To cover these different granularities,
we deﬁned the molecule types ‘family’, ‘isogroup’ (summar-
izing all products of one gene) and ‘basic’ (representing an
individual polypeptide to which we can assign, e.g. a sequence
and a molecular weight) (Figure 1). In fact, the type ‘family’ is
subject to a much ﬁner diversiﬁcation in a kind of ontology
described elsewhere (9).
For example, alternative splicing of mRNA encoded by
the human gene CDC25B, a cell cycle-relevant phosphatase,
results in several different polypeptides. Three of them,
Cdc25B1(h), Cdc25B2(h) and Cdc25B3(h) are included in
TRANSPATH  as type ‘basic’ molecule entries with an
assigned sequence. Since experimental results often do not
differentiate between these isoforms, a molecule entry of
type ‘isogroup’, Cdc25B(h), that represents the properties
of all isoforms of this gene, has been created. In some cases,
publicationsassign acertain signaling behaviortoCdc25with-
out indicating which gene is encoding the detected protein:
CDC25A, CDC25B or CDC25C. To be able to capture
this information correctly, the type ‘family’ molecule entry
Cdc25(h) has been introduced.
The requirement for another hierarchy comes from the fact
that many ‘canonical’ pathways that are commonly accepted
by the research community have been put together using data
from different organisms. Frequently, the individual publi-
cation does not even state explicitly the species a certain
molecule or gene that was used in the reported experiments
has been obtained from. Thus, we have to consider the pos-
sibility of ‘unknown’ values for certain attributes such as the
biological species. In addition, abstraction onto the level of
‘orthologous grouping’ helps to gain and keep overview of
a certain area. For these reasons, the molecule hierarchy
described above is superimposed by a correspondingly
structured layer of orthologs, leading to molecule entries of
‘orthofamily’, ‘orthogroup’ and ‘orthobasic’ type (Figure 1).
In addition, a new concept to represent PTMs of the
molecules at the different levels has been implemented. The
most basic feature of this representation is again that we need
to differentiate between very distinct degrees of granularity
Figure 1. Hierarchicalrelationsbetweenthedifferentmoleculetypesandtheirassignmentto thethree-layerreactionhierarchy.Linesindicatelinksbetweenitems.
Modifiedformsarerepresentedwiththeending_mod,e.g.basic_mod,orthocomplex_mod.Thiscanbeappliedtoanytype.Relationsbetweenthegeneandmolecule
table are shown with dashed lines.
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unkown’ has to be differentiated from ‘modiﬁcation status
(knowingly) irrelevant’ or ‘unmodiﬁed’, going deeper through
observations like ‘any phosphorylation’ required for a certain
purpose down to the detailed description of ‘phosphorylation
at Ser-n’ in a certain context. Further details of representing
PTM in TRANSPATH  have been described earlier (7).
TRANSPATH  provides information about the combinatorial
formation of multiprotein complexes. The same protein
(polypeptide) may be a part of several different complexes
and thus participate in different physiological functions within
the cell.
Having particular protein variants, PTMs and multiprotein
complexes as the separate entries in the Molecule table, we use
them as educts or products for reactions. This data model
allows to correctly reﬂect speciﬁc functions of particular
protein molecules.
Reaction hierarchy
We have now consistently modeled a three-layer reaction
hierarchy throughout the database. The most basic level stores
individual signaling reactions with all mechanistic details
available in the corresponding publication, such as the phos-
phorylation reaction
IRAKðv:s:Þþ2ATP   IRAK-4ðhÞ
! IRAKðv:s:ÞfpS376gfpT387gþ2ADP
(accession number XN000024244; note that writing IRAK-
4(h) as interrupt of the reaction arrow characterizes it as a
catalyst), or the binding reactions
TollipðmÞþIRAKðhÞ
, TollipðmÞ:IRAKðhÞð XN000003468Þ
and
IRAK-4ðhÞþIRAKðhÞ
, IRAK-4ðhÞ:IRAKðhÞð XN000024237Þ:
As can be seen, information about the species/taxon origin of
each molecule is included [(v.s.) for vertebrate species],
revealing that many of these experiments have been conducted
in a heterologous set-up. Examples are the transfection of
cells with constructs of mixed species origin for co-
immunoprecipitation studies (as for XN000003468) or the
use of bacterially expressed proteins in an in vitro kinase
assay with a rat enzyme and a human substrate. This reaction
level is called ‘evidence’ level.
Since several publications may have dealt with the same
reaction in a different experimental set-up, the evidence level
inevitably contains some redundancy. Moreover, if one pub-
lication may have shown the PTM of molecule A(species1)
by B(species2), another report may have demonstrated that
A(species3) physically interacts with B(species4) as it is
shown in the examples above. Since the interaction is a pre-
requisite for the modiﬁcation, these pieces of information are
summarized into one reaction stepon the next level. Itis called
‘pathway’ level since the corresponding reactions entries have
been optimized for constructing whole pathways out of them.
In this step, abstraction is also done for the biological species,
so that reactions on the pathway level usually involve ‘ortho-’
entries. However, they still model each reaction in a mechan-
istically ‘complete’ manner. Thus, the reaction given above
would now read
Tollip:IRAK þ IRAK-4 þ 2ATP
! Tollip:IRAKfpS376gfpT387g:IRAK-4
þ 2ADP ðXN000024253Þ
As can be seen, IRAK is a part of a complex with Tollip and
is actually phosphorylated within this complex. The kinase
IRAK-4 becomes also a part of the multiprotein complex.
This level is optimally used for constructing species-
independent ‘Reference Pathways’.
The third level is the ‘semantic’ projection of the contents
on the pathway level. In this kind of representation, only
those molecules are displayed which process and forward
the signal. Small ubiquitous molecules such as ATP or H2O
are omitted from the reaction equation, as is information about
complex and PTM status of the molecules. In turn, the roles
of these ‘semantic’ reactions have to be annotated explicitly
with terms like ‘binding’ and ‘phosphorylation’. The example
given above would now read:
IRAK-4 ! IRAK ðXN000024254Þ:
In addition to these three reaction types, we have deﬁned
‘indirect’ reactions and ‘decompositions’. The ﬁrst indicates
the existence of black boxes along the pathway which may
contain one or several as yet unidentiﬁed steps between the
upstream and the downstream molecules (or genes) of such a
reaction. Typically, indirect reactions are at the semantic level
since obviously, no mechanistic details can reasonably be
given for them. In contrast, virtual ‘decompositions’ are gen-
erally assigned to the pathway level and describe reactions
occurring within complexes as was discussed earlier in detail
(7). As a prerequisite, they require a complex formation reac-
tion to be modeled in the database beforehand.
Pathways
Individual signaling reactions are grouped to chains and path-
ways. Chains are sequences of individual reactions that have
been experimentally proven and reported to occur subse-
quently to each other. TRANSPATH  (public version 6.0)
provides pathway information by (i) graphical overviews
with click-able items that are available for the IL1 pathway
(the reaction examples given above are part of this pathway),
insulin pathway, p53 network, p53 phosphorylation map and
p73 network; and (ii) using the PathwayBuilder  (see below)
to construct complex pathways and signaling networks out of
the individual reactions stored.
The PathoSign module
The interference and dysfunction of intercellular signaling
pathways, e.g. caused by gene mutations, are involved in
the aetiology of a multitude of human diseases. To start coping
with these data and as a basis for the modeling of pathological
aberrations of signaling pathways we developed PathoSign,
a relational database which collects information about patho-
logically relevant mutations of signal transduction com-
ponents and their corresponding phenotypes. The database
D548 Nucleic Acids Research, 2006, Vol. 34, Database issuecomprises three main subjects, Mutated Molecules, Genotypes
and Phenotypes. To showcase database functionality,
PathoSign has been populated since its inception in March
2005 with data of  214 signaling molecule mutations
(Figure 2). Linked to these are tables that contain information
about the corresponding phenotypes (40 entries) and the
underlying genotypes (216 entries). The database is intended
as a stand-alone data repository as well as a disease-related
module of TRANSPATH . Mutated variants of the molecules
inPathoSignare linkedtothe corresponding normal molecules
in TRANSPATH  and genes encoding TRANSPATH 
molecules contain links to the corresponding disease-related
variants in PathoSign. In future, this extension, in federation
with additional resources, will encompass the modeling of
pathological aberrations of cell signaling pathways.
CONTENTS
All data in TRANSPATH  have been extracted from the full-
text original publications by manual curation. While being
maintained internally as a relational database, online access
is granted to a system of ﬂat ﬁles, comprising the text ﬁles
Molecule, Reaction and Gene. The number of entries in each
table is given in Table 1.
TRANSPATH  and PathoSign provide links to a number of
commonly used databases: GO terms (10), EMBL/GenBank/
DDBJ (11), ENSEMBL (12), RefSeq (13), UniProt (14),
Figure 2. PathoSignmutatedmoleculeview.Depictedisoneof14mutationsoftheribosomalS6kinase2gene(RSK2)whicharepresentlyannotated.TheCoffin–
LowrysyndromeiscausedbymutationsintheRSK2gene.Linkedtothemutatedmoleculeentryistherespectivegenotype(see‘InternalLinks’infigure),wherefrom
the phenotype entry referring to the Coffin–Lowry syndrome (PathoSign entry no. PTS00210) can be accessed.
Table 1. Number of entries in the TRANSPATH  6.0 public release in com-
parison with the previous public release, 5.1, as well as with the current
professional release
Table TRANSPATH
Public
Release 5.1
TRANSPATH
Public
Release 6.0
TRANSPATH
Professional
Release 6.2
Molecule 16894 20155 28779
Gene 4509 7603 11157
Reaction 20198 28126 52977
semantic 11579 17039 11098
pathway step 1343 1930 2111
molecular evidence 6153 7929 29875
Clickable maps 2 5 61
Pathways + Chains — — 406
Nucleic Acids Research, 2006, Vol. 34, Database issue D549EntrezGene (15), HGNC (16), MGI (17), RGD (18), InterPro
(19), AFFYMETRIX, OMIM (20) and TRANSFAC  (21).
DATA ACCESS AND VISUALIZATION
The search interface has been signiﬁcantly improved in com-
parison with the previous public release of TRANSPATH .
The new interface allows speciﬁcations by different operators
like ‘Entire words’, ‘Case sensitive’, ‘Fuzzy’ along with Boo-
leanoperators for logical operations on the search terms.Users
can deﬁne the output contents and results can be sorted by any
ﬁeld. Search results can be stored and subsequently reﬁned.
The contents of the database can be browsed. For this,
acomprehensiveclassiﬁcationofsignalingmoleculeshasbeen
developed which has been optimized for representing the
function of signaling molecules along the information ﬂow
(7). The main classes are: adaptors, chaperones, co-factors,
cytoskeletalproteins,enzymes,GTPase-controllingmolecules,
ligands, membrane-transducing components, transporters and
transcription factors.
TRANSPATH  is associated with the visualization tool
PathwayBuilder . With the help of this tool the signaling
network of TRANSPATH  can be traversed and visualized
dynamically.
To obtain customized views on the pathways and networks
of interest several parameters are available, such as network
expansion, pathway direction (upstream or downstream relat-
ive to a given molecule), number of steps, complexity as well
as different styles of the resulted view. A further functionality
enables highlighting molecules according to freely adjustable
ﬁlters; one can highlight, for instance, all adaptor proteins
within a given network or all human proteins. The resulting
visualizations can be saved and merged as necessary.
DISCUSSION
The TRANSPATH  database is used for different purposes,
some of which may overlap with the application of protein–
protein interaction networks, e.g. when interpreting gene
expression data. It should be noted, however, that both
types of networks exhibit some fundamental differences,
mainly: (i) in contrast to the protein–protein interaction net-
works, signal transduction paths are directed, since the ﬂow of
information throughthecellisdirected;(ii)signaltransduction
pathways also comprise many non-proteinaceous molecules as
essential items (e.g., steroids, phospholipids, inorganic ions,
nucleic acids); (iii) by including gene regulatory events, they
can be easily expanded to any number of ‘cycles’ of classical
signal transduction pathways, describing the path of a signal
from the membrane to, e.g. the nucleus. Therefore, protein–
protein interaction data cannot cover all requirements of
modeling functional processes in a cell, for which pathway-
oriented databases are needed.
TRANSPATH  is one of the few databases in the ﬁeld that
aims at providing information about signal transduction path-
ways, and presenting this information on different abstraction
levels of the reactions, and including all required molecular
information about PTMs and complexes. We feel that this
altogether may be a particular strength of TRANSPATH 
compared with other sources like STKE (http://www.stke.
org), AfCS (http://www.signaling-gateway.org/), Reactome
[http://www.reactome.org/ (22)], BioCarta (http://www.
biocarta.com) or the signaling part of KEGG [http://www.
genome.ad.jp/kegg/ (23)], each of them having its own par-
ticular strengths and weaknesses.
We see a further advantage of our system in the synergistic
potential between TRANSPATH  and PathoSign, which we
just started to fully exploit. It is one of the aims of our future
developments to make use of TRANSPATH  for modeling
complex signaling processes, and to include PathoSign con-
tents for exploring the (potential) far-reaching effects of muta-
tions in signaling components onto the overall signaling
network.
Another advantage of TRANSPATH  may be the sheer size
of the available information. Since signal transduction mech-
anisms are under intense investigation by biochemists and
molecular biologists since decades, there is an overwhelming
bodyof data available inthe literature.‘Complete’ coverageof
the sources is therefore nearly impossible to achieve, and even
an attempt of picking up all relevant reactions with at least a
few most important references attached is an enormous task.
Therefore,anydatabaseinthisﬁeld,includingTRANSPATH ,
is far from being ‘complete’ (in whatever sense). However,
compared with other resources, TRANSPATH  seems to have
a relatively good coverage of signaling reactions and path-
ways, which is rapidly expanding. Up to now, we refrained
from including automatically retrieved information in order to
keep quality and reliability of the data as high as possible.
However, we will make increased use of the data retrieval
pipeline established for the curation of the Proteome Data-
bases [http://www.proteome.com (24)] in future to increase
the efﬁciency of initial retrieval of relevant data, which we
will continue processing manually afterwards.
AVAILABILITY
TRANSPATH  Public release 6.0, which has been described
in this contribution, is freely accessible for users from non-
proﬁt organizations under http://www.gene-regulation.com/
pub/databases.html#transpath, the PathoSign module is freely
available under http://pathosign.bioinf.med.uni-goettingen.de/
or http://www.gene-regulation.com/pub/databases.html#
pathosign.
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